Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal.
Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal.
Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal. J Cardiovasc Nurs. 2003 Jan-Mar; 18(1):44-9; quiz 75-6.
View in:
PubMed
subject areas
Anticholesteremic Agents
Cholesterol, LDL
Coronary Disease
Humans
Hypercholesterolemia
Patient Selection
Practice Guidelines as Topic
Risk
Risk Assessment
authors with profiles
Michael H. Davidson